Rytol is a leading Canadian biopharmaceutical company focused on the discovery and development of innovative treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. The Company is using its proprietary GalXC RNAi technology platform to build a broad pipeline in these therapeutic areas.
Company Details
- Employees
- 1
- Founded
- 2012
- Address
- Greater Vancouver, British Columbia, Ca
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://rytolpharma.com
- Keywords
- Pharama, Biopharmaceutical, Health, Pharmaceutical.
- HQ
- Greater Vancouver, British Columbia
Rytol Pharma Questions
Rytol Pharma's website is http://rytolpharma.com
Rytol Pharma's LinkedIn profile is https://ca.linkedin.com/company/rytolpharma
Rytol Pharma has
1 employees.
View email and phone details for 1
employees at Rytol Pharma.
Rytol Pharma's industry is
Pharmaceutical Manufacturing
Rytol Pharma's top competitors are
Menamed Pharama Private Limited,
Medicotec,
Community Colleges For International Development- Ccid,
Webdoctors,
Uab School Of Nursing,
Surec Tech, Inc.,
Escr - European Society Of Cardiovascular Radiology,
Pharama.line,
Connected Minds Cfref,
Friends Of Parkinson's Inc..
Rytol Pharma's categories are Pharmaceutical Manufacturing
Rytol Pharma's founding year is 2012
